Cargando…
The impact of patient characteristics and lifestyle factors on the risk of an ipsilateral event after a primary DCIS: A systematic review
OBJECTIVE: The majority of ‘low-risk’ (grade I/II) Ductal Carcinoma In Situ (DCIS) may not progress to invasive breast cancer during a women’s lifetime. Therefore, the safety of active surveillance versus standard surgical treatment for DCIS is prospectively being evaluated in clinical trials. If pr...
Autores principales: | Alaeikhanehshir, Sena, Engelhardt, Ellen G., van Duijnhoven, Frederieke H., van Seijen, Maartje, Bhairosing, Patrick A., Pinto, Donna, Collyar, Deborah, Sawyer, Elinor, Hwang, Shelley E., Thompson, Alastair M., Wesseling, Jelle, Lips, Esther H., Schmidt, Marjanka K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073883/ https://www.ncbi.nlm.nih.gov/pubmed/32120064 http://dx.doi.org/10.1016/j.breast.2020.02.006 |
Ejemplares similares
-
Long-term risk of subsequent ipsilateral lesions after surgery with or without radiotherapy for ductal carcinoma in situ of the breast
por: van Seijen, Maartje, et al.
Publicado: (2021) -
Preferences of Treatment Strategies among Women with Low-Risk DCIS and Oncologists
por: Byng, Danalyn, et al.
Publicado: (2021) -
Active surveillance versus treatment in low-risk DCIS: Women’s preferences in the LORD-trial
por: Schmitz, Renée S.J.M., et al.
Publicado: (2023) -
Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study
por: Schmitz, Renée S J M, et al.
Publicado: (2023) -
DCIS and LCIS: Are the Risk Factors for Developing In Situ Breast Cancer Different?
por: Timbres, Jasmine, et al.
Publicado: (2023)